Emtricitabine + Rilpivirine + Tenofovir Disoproxil Fumarate Overview

Emtricitabine/rilpivirine/tenofovir (trade name Complera, Eviplera) is a fixed dose combination of antiretroviral drugs for the treatment of HIV.[1] The drug was co-developed by Gilead Sciences and Johnson & Johnson's Tibotec division and was approved by the Food and Drug Administration in August 2011, and by the European Medicines Agency in November 2011 (Eviplera),[2] for patients who have not previously been treated for HIV.[3] It is available as a once-a-day single tablet. References ...

Read more Emtricitabine + Rilpivirine + Tenofovir Disoproxil Fumarate Details
Details May Include Instructions, Side Effects, Interactions, Etc.
Drug monograph is from Wikipedia. All text is available under the terms of the GFDL
(GNU Free Documentation License) | http://en.wikipedia.org/wiki/Emtricitabine/rilpivirine/tenofovir

Recent Emtricitabine + Rilpivirine + Tenofovir Disoproxil Fumarate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Drugs with one or more similar ingredients: (11 results)

Possibly related Emtricitabine + Rilpivirine + Tenofovir Disoproxil Fumarate Topics: